Ganirelix acetate, an injectable medication used in assisted reproductive technologies, helps prevent premature ovulation [1]. It is a GnRH antagonist, meaning it blocks the action of gonadotropin-releasing hormone, which is necessary for the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) [2]. By doing so, it synchronizes the growth of follicles and allows for controlled egg retrieval [1].
How does ganirelix acetate work to prevent ovulation?
Ganirelix acetate works by directly binding to GnRH receptors in the pituitary gland. This prevents GnRH from binding to its own receptors, thereby suppressing the surge of LH that typically triggers ovulation. This suppression is rapid and reversible, providing precise control over the timing of ovulation [2].
What is the typical dosage and administration of ganirelix acetate?
The standard dosage for ganirelix acetate is typically a subcutaneous injection of 0.25 mg once daily. Treatment usually begins on the morning of the sixth day of stimulation in a standard in vitro fertilization (IVF) cycle. The medication is administered until the day of final maturation injection, also known as the trigger shot [1].
When does ganirelix acetate patent exclusivity expire?
Information regarding specific patent expiry dates for ganirelix acetate can be found on specialized drug patent tracking websites. For instance, DrugPatentWatch.com provides details on patent status and expiry timelines for many pharmaceuticals [3].
What are the potential side effects of ganirelix acetate?
Common side effects associated with ganirelix acetate include injection site reactions such as redness, itching, and swelling. Other reported side effects may include headache and nausea [1]. Serious allergic reactions are rare but possible [2].
Who manufactures ganirelix acetate?
Ganirelix acetate is manufactured by several pharmaceutical companies. In the United States, it is marketed under the brand name Cetrotide by EMD Serono, a subsidiary of Merck KGaA [1]. Other manufacturers may produce generic versions of the drug [3].
Are there any alternatives to ganirelix acetate for ovulation control?
GnRH agonists are another class of drugs used to control ovulation in IVF cycles. These drugs initially stimulate GnRH receptors, leading to a flare effect, followed by desensitization and suppression. However, GnRH antagonists like ganirelix acetate offer a more immediate and controllable suppression, often leading to fewer side effects and a potentially shorter stimulation cycle [2].
What clinical data supports the use of ganirelix acetate?
Clinical trials have demonstrated that ganirelix acetate is effective in preventing premature LH surges in women undergoing controlled ovarian stimulation. Studies have shown comparable or improved outcomes in terms of oocyte yield and pregnancy rates when compared to older methods of ovulation induction [1][2].
What is the cost of ganirelix acetate and are there coupons or discounts available?
The cost of ganirelix acetate can vary significantly based on the pharmacy, insurance coverage, and whether a generic version is available. Patients may be able to find savings through manufacturer-sponsored patient assistance programs, pharmacy discount cards, or coupons offered by third-party discount providers. Checking with specific pharmacies or patient support services is recommended for current pricing and potential discounts [3].
What are the regulatory approvals for ganirelix acetate?
Ganirelix acetate has received approval from regulatory agencies in various countries, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), for its use in assisted reproductive technologies [1][2].
Sources:
[1] https://www.emdserono.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.drugpatentwatch.com/